Seokheun “Sean” Choi, an associate professor of electrical and computer engineering, has developed a new device for faster testing of antibiotic-resistant bacteria.
Bacterial infections have become one of the biggest health problems worldwide, and a recent study shows that COVID-19 patients have a much greater chance of acquiring secondary bacterial infections, which significantly increases the mortality rate.
Combatting the infections is no easy task, though. When antibiotics are carelessly and excessively prescribed, that leads to the rapid emergence and spread of antibiotic-resistant genes in bacteria — creating an even larger problem. According to the Centers for Disease Control and Prevention, 2.8 million antibiotic-resistant infections happen in the U.S. each year, and more than 35,000 people die from of them.
One factor slowing down the fight against antibiotic-resistant bacteria is the amount of time needed to test for it. The conventional method uses extracted bacteria from a patient and compares lab cultures grown with and without antibiotics, but results can take one to two days, increasing the mortality rate, the length of hospital stay and overall cost of care.
Associate Professor Seokheun “Sean” Choi — a faculty member in the Department of Electrical and Computer Engineering at Binghamton University’s Thomas J. Watson College of Engineering and Applied Science — is researching a faster way to test bacteria for antibiotic resistance.
“To effectively treat the infections, we need to select the right antibiotics with the exact dose for the appropriate duration,” he said. “There’s a need to develop an antibiotic-susceptibility testing method and offer effective guidelines to treat these infections.”
In the past few years, Choi has developed several projects that cross “papertronics” with biology, such as one that developed biobatteries using human sweat.
This new research — titled “A simple, inexpensive, and rapid method to assess antibiotic effectiveness against exoelectrogenic bacteria” and published in November’s issue of the journal Biosensors and Bioelectronics — relies on the same principles as the batteries: Bacterial electron transfer, a chemical process that certain microorganisms use for growth, overall cell maintenance and information exchange with surrounding microorganisms.
“We leverage this biochemical event for a new technique to assess the antibiotic effectiveness against bacteria without monitoring the whole bacterial growth,” Choi said. “As far as I know, we are the first to demonstrate this technique in a rapid and high-throughput manner by using paper as a substrate.”
Working with PhD students Yang Gao (who earned his degree in May and is now working as a postdoctoral researcher at the University of Texas at Austin), Jihyun Ryu and Lin Liu, Choi developed a testing device that continuously monitors bacteria’s extracellular electron transfer.
A medical team would extract a sample from a patient, inoculate the bacteria with various antibiotics over a few hours and then measure the electron transfer rate. A lower rate would mean that the antibiotics are working.
“The hypothesis is that the antiviral exposure could cause sufficient inhibition to the bacterial electron transfer, so the readout by the device would be sensitive enough to show small variations in the electrical output caused by changes in antibiotic effectiveness,” Choi said.
The device could provide results about antibiotic resistance in just five hours, which would serve as an important point-of-care diagnostic tool, especially in areas with limited resources.
The prototype — built in part with funding from the National Science Foundation and the U.S. Office of Naval Research — has eight sensors printed on its paper surface, but that could be extended to 64 or 96 sensors if medical professionals wanted to build other tests into the device.
Building on this research, Choi already knows where he and his students would like to go next: “Although many bacteria are energy-producing, some pathogens do not perform extracellular electron transfer and may not be used directly in our platform. However, various chemical compounds can assist the electron transfer from non-electricity-producing bacteria.
“For instance, E. coli cannot transfer electrons from the inside of the cell to the outside, but with the addition of some chemical compounds, they can generate electricity. Now we are working on how to make this technique general to all bacteria cells.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Bacterial infections
- Common antibiotic Neosporin may shield against viral respiratory infections
A study conducted first in mice and then in human volunteers suggests that a common antibiotic, neomycin, which is the main active ingredient in Neosporin, may help protect against viral respiratory ...
- Study details a common bacterial defense against viral infection
One of the many secrets to bacteria's success is their ability to defend themselves from viruses, called phages, that infect bacteria and use their cellular machinery to make copies of themselves.
- New structures offer insight into how a bacterial motor powers bacterial chemotaxis, a key infectious process
Bacteria existed for millennia before humans and have been infecting us from the beginning. Although we can treat infections through pharmaceuticals, bacteria continue to become resistant to treatment ...
- Coventry mum who died of bacterial infection thought illness was 'just a winter bug'
An ECMO machine which breathes for people outside the lungs was considered and an enquiry made to another hospital, but ultimately it was not used. During treatment for the pneumothorax on 11 December ...
- FDA approves new medication for uncomplicated urinary tract infections in women
The newly approved oral medication Pivya provides women with another option for treating uncomplicated urinary tract infections, the U.S. Food and Drug Administration announced Wednesday.
Go deeper with Google Headlines on:
Bacterial infections
[google_news title=”” keyword=”lithium” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Antibiotic-resistant bacteria
- Common antibiotic Neosporin may shield against viral respiratory infections
A study conducted first in mice and then in human volunteers suggests that a common antibiotic, neomycin, which is the main active ingredient in Neosporin, may help protect against viral respiratory ...
- Study: Antibiotic use in patients hospitalized with COVID-19 appears to have no beneficial effect on clinical outcomes
Antibiotic treatment of adults hospitalized with moderate COVID-19 is associated with clinical deterioration, despite the drugs being given to over 40% of patients, according to new research being ...
- A Vaccine to Fight Antibiotic Resistance
MSU, Harvard Medical School team up to expand vaccine science’s role in the fight against MRSA and other infections ...
- Researchers develop vaccine to fight antibiotic resistance
Driven by the overuse of antimicrobials, pathogens are quickly building up resistances to once-successful treatments. It’s estimated that antimicrobial-resistant infections killed more than 1 million ...
- Study suggests spread of drug-resistant bacteria from people to nature
A group of researchers at institutions including Japan's Hokkaido University says a study has found that drug-resistant bacteria may be spreading from human society to aquatic environments and ...
Go deeper with Google Headlines on:
Antibiotic-resistant bacteria
[google_news title=”” keyword=”antibiotic-resistant bacteria” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]